ARVL - VXRT REGI ARVL and CRNT among premarket gainers

BioLineRx (BLRX) +62% on positive top-line results from GENESIS phase 3 trial.Cocrystal Pharma (COCP) +40%.Huttig Building Products, Inc. (HBP) +26% on Q1 results.Vaxart (VXRT) +20% as its oral COVID-19 vaccine shows potential to offer promising solution against variants.Precipio (PRPO) +20%.51job (JOBS) +14% on receiving updated non-binding proposal to go private at $79.05/share.Arrival (ARVL) +11% on EV partnership with UberRenewable Energy Group (REGI) +9%.Ceragon Networks (CRNT) +6%.Enveric Biosciences (ENVB) +7%.ProQR Therapeutics N.V. (PRQR) +6% as Yarrow Biotechnology has in-licensed exclusive rights to ProQR’s antisense oligonucleotide technology.GeoVax Labs (GOVX) +6%.DBV Technologies S.A. (DBVT) +6%.

For further details see:

VXRT, REGI, ARVL and CRNT among premarket gainers